You are here: Home » News-CM » Companies » News
Business Standard

Zydus receives final approval from the USFDA for Acetazolamide ER Capsules

Capital Market 

Zydus Cadila has received the final approval from the USFDA to market Acetazolamide ER Capsules (US RLD Diamox).

It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide ER capsules are used to treat certain types of glaucoma (caused by increased ocular pressure) and to treat or prevent altitude sickness (acute mountain sickness).

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, January 17 2019. 12:58 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU